Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643236PMC
http://dx.doi.org/10.1016/s0828-282x(08)70705-0DOI Listing

Publication Analysis

Top Keywords

fistula coronary
4
coronary artery
4
artery bypass
4
bypass graft
4
graft pseudoaneurysm
4
pseudoaneurysm coronary
4
coronary sinus
4
fistula
1
artery
1
bypass
1

Similar Publications

Comparison of Embolization Coils and Patent Ductus Arteriosus Occluders for Coronary Artery Fistula Transcatheter Closure: A Single Centre Experience.

Korean Circ J

November 2024

Department of Structural Heart Disease, National Center for Cardiovascular Disease & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.

Background And Objectives: There is no dedicated occlusive device for closing coronary artery fistulas (CAFs), and specific efficacy and safety data of various off-label occlusive devices for CAFs closure are scarce.

Methods: Patients undergoing transcatheter closure of CAFs from January 2011 to December 2022 were included in the single-center retrospective study. The study population was divided into 2 groups: coils group (n=35) and patent ductus arteriosus (PDA) occluders group (n=66).

View Article and Find Full Text PDF

Transesophageal Echocardiographic Identification of an Inadvertent Coronary Vein Bypass Graft.

J Cardiothorac Vasc Anesth

December 2024

Department of Anesthesiology and the Department of Cardiac Surgery, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada. Electronic address:

View Article and Find Full Text PDF

It is well established that host immunity plays a critical role in defending against colorectal cancer (CRC) progression. Connective tissue disease (CTD) encompasses a group of heterogeneous, immune-mediated disorders that present with diverse and often non-specific initial symptoms. Raynaud's phenomenon is a common feature, complicating early diagnosis.

View Article and Find Full Text PDF

Introduction: Proactive esophageal cooling reduces injury during radiofrequency (RF) ablation of the left atrium (LA) for the treatment of atrial fibrillation (AF). New catheters are capable of higher wattage settings up to 90 W (very high-power short duration, vHPSD) for 4s. Varying power and duration however does not eliminate the risk of thermal injury.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!